Revascularization interventions for ischemic heart disease

Current Opinion in Cardiology

Volumn 15, Issue 6, 2000, Pages 463-471

  Moustapha, Ali ^a   Anderson, H Vernon ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHERECTOMY; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; THROMBECTOMY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; CORONARY ARTERY BYPASS; HUMANS; LASER SURGERY; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS; STENTS; TREATMENT OUTCOME;

EID: 0033679023     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200011000-00012     Document Type: Review

References (90)

1. The coronary circulation. The Williams F Reinhoff, Jr. lecture
2. Aortocoronary bypass with saphenous vein graft. Seven-year follow-up
3. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina
4. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study
5. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study
6. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events
7. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
8. Off pump multivessel coronary bypass via sternotomy is safe and effective
9. Coronary artery bypass on the beating heart with the Octopus: A North American experience
10. Angiographic results after minimally invasive coronary bypass grafting using the minimally invasive direct coronary bypass grafting (MIDCAB) approach
11. Early experience with minimally invasive direct coronary artery bypass grafting with the internal thoracic artery
12. Comparison of post-operative pain, stress response, and quality of life in port access vs standard sternotomy coronary bypass patients
13. Coronary artery bypass grafting via median sternotomy or lateral minithoracotomy
14. Port-access minimally invasive cardiac surgery increases surgical complexity, increases operating room time, and facilitates early postoperative discharge
15. Myocardial 'hybrid' revascularisation with minimally invasive direct coronary artery bypass grafting combined with coronary angioplasty: Preliminary results of a multicentre study
16. Transluminal treatment of arteriosclerotic obstruction: Description of a new technic and preliminary report of its application. 1964
17. Coronary transluminal angioplasty, abstracted
18. Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME investigators. Angioplasty Compared to Medicine
19. Quality of life after coronary angioplasty or continued medical treatment for engine: Three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina
20. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization
21. Five-year follow-up of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending artery stenosis
22. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators
23. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): In-hospital results and 1-year follow-up. ERACI Group
24. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation
25. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial
26. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation)
27. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
28. Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial
29. Long-term results of RITA-1 trial: Clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina
30. Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. A prospective trial
31. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease
32. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
33. Eight-year mortality in the Emory Angioplasty versus Surgery Trial
34. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment, diabetic status
35. Effects of endoluminal coronary stents on the frequency of coronary artery bypass grafting after unsuccessful percutaneous transluminal coronary vascularization
36. Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2242 patients
37. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group
38. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
39. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery
40. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators
41. Primary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA)
42. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: The Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial
43. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial
44. The ARTS study (Arterial Revascularization Therapies Study)
45. Complementary clinical benefits of coronary-artery stenting and blockage of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators
46. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
47. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study
48. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators
49. A call for provisional stenting: The balloon is back!
50. The French randomized optimal stenting trial: A prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography
51. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): Immediate and long-term follow-up results
52. Influence of lesion length on restenosis after coronary stent placement
53. Predictors of diffuse-type in-stent restenosis after coronary stent implantation
54. Angiographic and intravascular ultrasound predictors of in-stent restenosis
55. In-stent restenosis: The Washington Hospital Center experience
56. Device influence on outcome in the treatment of in-stent restenosis with and without radiation. A subanalysis from the WRIST study
57. Treatment of in-stent restenosis. Shall we balloon or stent the stent? A prospective single center randomized study
58. Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis
59. Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis
60. Stenting for in-stent restenosis: A long term clinical follow-up
61. Intracoronary gamma radiation for the prevention of recurrent in-stent restenosis: Final results from the gamma-1 trial
62. Three-year clinical and angiographic follow-up after intracoronary radiation: Results of a randomized clinical trial
63. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis
64. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT study group
65. Final results of the balloon vs optimal atherectomy trial
66. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II investigators
67. Stenting after optimal lesion debulking (SOLD) registry: Angiographic and clinical outcome
68. Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) study
69. Rotational atherectomy: Improved procedural outcome with evolution of technique and equipment. Single-center results of first 1,000 patients
70. Rotational atherectomy: New technology, improved technique, and better results
71. Rotational coronary atherectomy of ostial stenoses
72. Rotational atherectomy: A new treatment modality for ostial stenoses of 'stent-jailed' side branches
73. Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions
74. Transmyocardial laser revascularization: Anatomic evidence of long term channel patency
75. Histological appearance of transmyocardial laser channels after 4 1/2 weeks
76. Angiogenesis is enhanced in ischaemic canine myocardium by transmyocardial laser revascularization
77. Cardiac sympathetic denervation after transmyocardial laser revascularization
78. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease
79. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina
80. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomised trial
81. Transmyocardial laser revascularization in patients with refractory angina: A randomised controlled trial
82. Transmyocardial laser revascularization with the CO2 laser: One year results of a randomized, controlled trial
83. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial
84. Factors correlating with risk of mortality after transmyocardial revascularization
85. Periopeartive morbidity and mortality after transmyocardial laser revascularization: Incidence and risk factors for adverse events
86. Percutaneous direct myocardial revascularization guided by Biosense left ventricular mapping in patients with refractory coronary ischaemic syndromes
87. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease
88. Percutaneous direct myocardial revascularization: Safety and feasibility of high-density myocardial laser therapy and 1-month follow-up
89. Percutaneous myocardial revascularization (PMR): Initial results from the PACIFIC trial
90. Six month follow-up of a prospective randomized trial of percutaneous transmyocardial revascularization vs medical therapy in patients with refractory angina